Chemokine Decoy Receptor D6 Plays a Negative Role in Human Breast Cancer
Chemokine binding protein D6 is a promiscuous decoy receptor that can inhibit inflammation in vivo ; however, the role it plays in cancer is not well known yet. In this study, we showed for the first time that human breast cancer differentially expressed D6 and the expression could be regulated by s...
Saved in:
Published in | Molecular cancer research Vol. 6; no. 8; pp. 1276 - 1288 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
American Association for Cancer Research
01.08.2008
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Chemokine binding protein D6 is a promiscuous decoy receptor that can inhibit inflammation in vivo ; however, the role it plays in cancer is not well known yet. In this study, we showed for the first time that human breast
cancer differentially expressed D6 and the expression could be regulated by some cytokines. More importantly, overexpression
of D6 in human breast cancer cells inhibits proliferation and invasion in vitro and tumorigenesis and lung metastasis in vivo . This inhibition is associated with decreased chemokines (e.g., CCL2 and CCL5), vessel density, and tumor-associated macrophage
infiltration. Furthermore, D6 expression is inversely correlated to lymph node metastasis as well as clinical stages, but
positively correlated to disease-free survival rate in cancer patients. Therefore, D6 plays a negative role in the growth
and metastasis of breast cancer. (Mol Cancer Res 2008;6(8):1276–88) |
---|---|
ISSN: | 1541-7786 1557-3125 |
DOI: | 10.1158/1541-7786.MCR-07-2108 |